advertisement
Lu F 10
Showing records 1 to 10 | Display all abstracts from Lu F90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Aihara M
American Journal of Ophthalmology 2020; 220: 53-63
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Aihara M
Japanese Journal of Ophthalmology 2020; 64: 398-406
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Lu F
American Journal of Ophthalmology 2020; 220: 53-63
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Ropo A; Lu F
Japanese Journal of Ophthalmology 2020; 64: 398-406
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Kawata H; Iwata A
American Journal of Ophthalmology 2020; 220: 53-63
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Kawata H
Japanese Journal of Ophthalmology 2020; 64: 398-406
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Odani-Kawabata N
American Journal of Ophthalmology 2020; 220: 53-63
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Iwata A
Japanese Journal of Ophthalmology 2020; 64: 398-406
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Shams NK
American Journal of Ophthalmology 2020; 220: 53-63
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Odani-Kawabata N; Shams N
Japanese Journal of Ophthalmology 2020; 64: 398-406
